Safety and Tolerability of Xanthohumol in Adults With Crohn's Disease: Results of a Triple‐Masked, Randomized, Placebo‐Controlled Phase 2 Trial

Documenti analoghi

• Modulation of Microbiota‐Derived Bile Acids Linked to Symptom Amelioration in Crohn's Disease: Insights From a Randomized Clinical Trial With Xanthohumol Supplementation
  di: Paige E. Jamieson, et al.
  Pubblicazione: (2026)
• Probiotic Lactiplantibacillus plantarum Probio87 Improves Gut Microbial Profiles in HPV‐Positive Women: A Randomized, Placebo‐Controlled and Double‐Blind Study
  di: Pei Xu, et al.
  Pubblicazione: (2025)
• Tomato Puree Enrichment in a High‐Fat Meal Reduces Postprandial Plasma and Adipose Tissue Inflammation Biomarkers in Healthy Male Adults: A Crossover Randomized Controlled Trial
  di: Lea Sani, et al.
  Pubblicazione: (2025)
• Effect of Single Oral Coingestion of GABA and Malic Acid on Postprandial GLP‐1, Glucose, and Insulin Responses in Healthy Volunteers: A Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study
  di: Hiroki Noguchi, et al.
  Pubblicazione: (2024)
• Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns
  di: Jordan Stanford, et al.
  Pubblicazione: (2025)